July 2025 Life Sciences Mega Close: Frazier Life Sciences Closes $1.3B Fund XII
Frazier Life Sciences closed Fund XII at over $1.3 billion on July 31, 2025 — one of the largest biotech venture funds closed in July 2025.
2026 venture capital activity reflects a market balancing AI infrastructure bets, selective growth equity, and renewed interest in capital-efficient startups. Our coverage tracks the rounds, fund launches, and strategic shifts that matter for founders and investors.
Read the latest 2026 VC news and funding roundups below.
Frazier Life Sciences closed Fund XII at over $1.3 billion on July 31, 2025 — one of the largest biotech venture funds closed in July 2025.
Greenwich and Miami-based Glade Brook Capital closed Strategic Growth Fund IV at $515 million on July 22, 2025, targeting FinTech, AI, SpaceTech, and DefenseTech growth equity.
Houston-based Modi Ventures closed its oversubscribed second fund at $88 million on July 16, 2025, investing at the intersection of AI, biology, and medical technology.
Former Coatue partner Kris Fredrickson closed Verified Capital Fund I at $175M in July 2025 — a concentrated 8–10 bet strategy backed by Harvey AI, Coinbase, and Instacart founders.
San Francisco-based Propel Venture Partners closed Fund V at $100 million on July 11, 2025, bringing total commitments to $436M+ for fintech infrastructure seed investing.
Solo GP Sarah Smith closed Fund I at $16 million in July 2025, deploying AI-native tools to back up to 50 pre-seed and seed companies with $250K average checks.